Items where Author is "Afshar, B."

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 1.

Article

Merat, S. and Poustchi, H. and Sharifi, A-H and Nateghi, A. and Hajiani, E. and Gharavi, A. and Somi, M-H and Ghadir, M-R and Kalantari, H. and Mansour-Ghanaei, F. and Karimi, J. and Fattahi, M-R and Baniasadi, N. and Moosavy, S. and Dehghan-Manshadi, S-A and Sofian, M. and Sayad, B. and Abazar, P. and Amiriani, T. and Bakhshipour, A. and Mokhtare, M. and Sharifian, A. and Minakari, M. and Zahedi, M. J. and Sohrabi, M. and Ghezloo, M. and Jamali, R. and Toosi, S. M. V. and Afshar, B. and Maleki, I. and Ziaee, M. and Hormati, A. and Samani, F. R. and Eslami, L. and Fakheri, H. and Goshayeshi, L. and Sali, S. and Sohrabpour, A. A. and Norouzi, A. and Sardarian, H. and Janbakhsh, A. and Shayesteh, A. A. and Ahmadi, L. and Merat, D. and Shayesteh, E. and Malekzadeh, R. SD1000: 96.4% SVR12 in 1237 patients with hepatitis C genotypes 1, 2, 3, 4 using co-formulated sofosbuvir/daclatasvir tablets manufactured in Iran - a multicenter phase 3 clinical trial including HIV co-infected, transplant, and hemodialysis patients. JOURNAL OF VIRAL HEPATITIS, 25 (2, SI). pp. 198-199.

This list was generated on Wed Oct 21 15:16:42 2020 EDT.